Analogic’s Q4, fiscal 1999, results slip

Article

Continued weakness in the Asian and South American markets helped bring in disappointing financial results for Analogic in its fiscal 1999 (end-July). Sales for the year were $279.7 million, down 10.8% from 1998’s $294.5 million, while annual net

Continued weakness in the Asian and South American markets helped bring in disappointing financial results for Analogic in its fiscal 1999 (end-July). Sales for the year were $279.7 million, down 10.8% from 1998’s $294.5 million, while annual net income was $19.5 million, compared with $23.9 million in the same period in 1998.

In the fourth quarter, Analogic had sales of $69 million, down 15.3% from the previous year’s $81.5 million. The Peabody, MA-based company’s net income for the quarter was $3.9 million, compared with $7.2 million in the fourth quarter of 1998. In addition to softness in the Asian and South American markets, Analogic also pointed to costs it sustained for new engineering projects, for start-ups, and to ensure Y2K compliance for its products.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.